Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$2.5B |
| 2 |
Apple
AAPL
|
+$1.68B |
| 3 |
Tesla
TSLA
|
+$951M |
| 4 |
Johnson & Johnson
JNJ
|
+$750M |
| 5 |
UnitedHealth
UNH
|
+$703M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CTXS
Citrix Systems Inc
CTXS
|
+$913M |
| 2 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$257M |
| 3 |
NVIDIA
NVDA
|
+$225M |
| 4 |
Vertiv
VRT
|
+$164M |
| 5 |
JPMorgan Chase
JPM
|
+$161M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 12.48% |
| 2 | Healthcare | 7.36% |
| 3 | Financials | 6.5% |
| 4 | Consumer Discretionary | 5.35% |
| 5 | Industrials | 3.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
LBAI
2301
DELISTED
Lakeland Bancorp Inc
LBAI
| $1.76M | ﹤0.01% |
99,668
-7,126
| -7% | -$127K |
|
2302
iShares 5-10 Year Investment Grade Corporate Bond ETF
IGIB
$18.6B
| $1.75M | ﹤0.01% |
35,387
-39,737
| -53% | -$1.95M |
|
2303
Cogent Communications
CCOI
$546M
| $1.75M | ﹤0.01% |
30,681
-21,576
| -41% | -$1.18M |
|
|
RSX
2304
DELISTED
VanEck Russia ETF
RSX
| $1.75M | ﹤0.01% |
309,846
-150,000
| -33% | -$848K |
|
2305
APi Group
APG
$17.8B
| $1.75M | ﹤0.01% |
139,595
+47,229
| +51% | +$545K |
|
2306
CALL
Atlassian
TEAM
$28B
| $1.75M | ﹤0.01% |
+13,600
| New | +$2.16M |
|
|
VNET
2307
VNET Group
VNET
$2B
| $1.74M | ﹤0.01% |
307,144
| – | – |
|
2308
PUT
FuboTV Inc
FUBO
$265M
| $1.74M | ﹤0.01% |
+83,333
| New | +$3.05M |
|
2309
Corcept Therapeutics
CORT
$11.7B
| $1.74M | ﹤0.01% |
85,534
+1,915
| +2% | +$48K |
|
2310
iShares Latin America 40 ETF
ILF
$3.8B
| $1.74M | ﹤0.01% |
75,811
+21,567
| +40% | +$536K |
|
2311
Marcus & Millichap
MMI
$1.2B
| $1.73M | ﹤0.01% |
50,301
+4,125
| +9% | +$146K |
|
2312
GXO Logistics
GXO
$5.41B
| $1.73M | ﹤0.01% |
40,470
+21,162
| +110% | +$849K |
|
2313
CALL
Coty
COTY
$2.39B
| $1.72M | ﹤0.01% |
+200,800
| New | +$1.47M |
|
2314
PUT
AMC Entertainment Holdings
AMC
$2.29B
| $1.72M | ﹤0.01% |
+42,190
| New | +$2.66M |
|
2315
PUT
DuPont de Nemours
DD
$19.5B
| $1.72M | ﹤0.01% |
+19,917
| New | +$1.59M |
|
2316
IDEAYA Biosciences
IDYA
$3.49B
| $1.71M | ﹤0.01% |
94,343
+23,735
| +34% | +$399K |
|
2317
Central Garden & Pet Co Class A
CENTA
$2.54B
| $1.71M | ﹤0.01% |
59,631
+12,956
| +28% | +$389K |
|
2318
Telos
TLS
$342M
| $1.71M | ﹤0.01% |
335,284
+17,480
| +6% | +$116K |
|
2319
Simply Good Foods
SMPL
$988M
| $1.69M | ﹤0.01% |
44,473
+13,981
| +46% | +$516K |
|
|
PANA
2320
DELISTED
Panacea Acquisition Corp. II Class A Ordinary Shares
PANA
| $1.69M | ﹤0.01% |
167,982
| – | – |
|
2321
FLEX LNG
FLNG
$1.68B
| $1.69M | ﹤0.01% |
51,595
-48,726
| -49% | -$1.63M |
|
2322
Amkor Technology
AMKR
$13.5B
| $1.68M | ﹤0.01% |
70,147
+1,407
| +2% | +$32.6K |
|
2323
Autohome
ATHM
$2.62B
| $1.68M | ﹤0.01% |
54,906
-14,614
| -21% | -$434K |
|
2324
Adient
ADNT
$1.48B
| $1.68M | ﹤0.01% |
48,358
+40,123
| +487% | +$1.4M |
|
2325
Community Trust Bancorp
CTBI
$1.42B
| $1.67M | ﹤0.01% |
36,425
+3,421
| +10% | +$156K |
|
Similar funds
Barclays's Q4 2022 Portfolio in Review
As of Q4 2022, Barclays held 5,646 positions worth $223B, up 144% from $91.6B the previous quarter. Its ten largest holdings account for 41% of the portfolio.
Barclays deployed $128B of net new capital in Q4 2022, opening 797 new positions and adding to 2,634 existing holdings. Its largest new stake was Seadrill: 1,546,558 shares worth $50.5M.
By sector, the portfolio is most concentrated in Technology at 12% of assets, down from 23% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Horizon Therapeutics Public Limited Company Ordinary Shares, an estimated $257M trimmed.
- Barclays's largest Q4 2022 buy was Seadrill: 1,546,558 shares worth $50.5M.
- Barclays added most to Microsoft in Q4 2022, an estimated $2.5B increase.
- Barclays's biggest Q4 2022 reduction was Horizon Therapeutics Public Limited Company Ordinary Shares, cutting an estimated $257M.
- Barclays fully exited Citrix Systems Inc in Q4 2022, selling an estimated $913M.
- Barclays's ten largest holdings make up 41% of its $223B portfolio in Q4 2022.
- Barclays opened 797 new positions and closed 385 in Q4 2022.
- Barclays's portfolio value rose 144% quarter-over-quarter to $223B.
Based on Barclays's 13F filing for Q4 2022, filed 13 Feb 2023.